Parliamentary group criticises regulators for their treatment of challenger banks during Covid-19
A new report from a cross party group of MPs has slammed the UK's regulators for not keeping the neobanks and building societies at the front of mind during the pandemic.
Check out these 32 RegTech funding rounds from July
In the midst of the Covid-19 crisis, these 32 RegTech companies have successfully secured funding over the last month.
Clarilis bags £6m in its Series B
Clarilis, a document automation platform, has bagged £6m in its Series B round, which is going to help the international expansion of the company.
Silverfort nets $30m in its Series B as remote working boosts customer demand
Silverfort, a proxyless authentication platform, has netted $30m in its Series B round, which will help it meet rising customer demand.
userlane said to secure €10m in a Series B round
Digital adoption software platform userlane has reportedly secured a €10m Series B round to support its European expansion.
Liopa secures £40m funding package from the UK government
Northern Ireland-based Liopa, which offers automated lip reading technology, has been awarded a £40m package from the UK government.
The grant has been given to...
Group-IB receives grant from Singapore’s cybersecurity initiative
Threat hunting and intelligence company Group-IB has received a grant as part of Singapore’s Cybersecurity Industry Call.
Spyderbat raises $2.4m in fudning as it preps for launch
Cybersecurity platform Spyderbat has raised $2.4m in its seed funding round, which was led by LiveOak Venture Partners and Benhamou Global Ventures.
Ten biggest RegTech deals since the Covid-19 lockdown
The RegTech sector has seen some massive investment rounds in the past few months despite the global pandemic.
ECB chair calls for banking bosses to “adopt extreme moderation” when it comes to...
The European Central Bank chair of the supervisory board has called for bank executives around Europe to show restraint when it comes to variable remunerations in the face of the coronavirus.
